🔎 Trials Near Me

Akèy › Maladi poumon entèstisyèl › Colorado

Etid klinik pou Maladi poumon entèstisyèl nan Colorado

15 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan Colorado.

Vil nan Colorado

Tèks ofisyèl etid la (Anglè)

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

  • University of Colorado Denver, Aurora
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07201922

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • University of Colorado, Denver
  • National Jewish Hospital, Denver
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 29, 2026 · NCT05798923

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, Aurora
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05878717

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  • National Jewish Health, Denver
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06968845

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  • University of Colorado Hospital, Aurora
  • National Jewish Hospital, Denver
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 2, 2026 · NCT07285655

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • University of Colorado - Anschutz Medical Campus, Aurora
  • National Jewish Health, Denver
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

  • University of Colorado | Anschutz Medical Campus, Aurora
Ap rekriteEtid obsèvasyon
Laj 18 a 80 · Tout sèks · Mizajou Aug 18, 2026 · NCT06855329

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • University of Colorado, Aurora
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT01915511

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

  • National Jewish Health, Denver
Ap rekriteEtid obsèvasyon
Laj 18 a 80 · Tout sèks · Mizajou Jun 26, 2026 · NCT06129240

A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

  • GSK Investigational Site, Aurora
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Jun 22, 2026 · NCT06576271

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

  • Children's Hospital Colorado, Aurora
Ap rekriteEtid obsèvasyon
Jiska laj 24 · Tout sèks · Mizajou Jun 22, 2026 · NCT04098445

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

  • University of Colorado - Anschutz Medical Campus, Aurora
Ap rekriteEtid obsèvasyon
Laj 45 a 90 · Tout sèks · Mizajou May 1, 2026 · NCT03297775

Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

  • University of Colorado Denver, Aurora
Ap rekriteEtid obsèvasyon
Laj 18 a 90 · Tout sèks · Mizajou May 3, 2024 · NCT06397677

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.